This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Feb 1;20(3):620-3.

doi: 10.1200/JCO.2002.20.3.620.

Can we cure limited metastatic breast cancer?

Gabriel N Hortobagyi

PMID: 11821439
DOI: 10.1200/JCO.2002.20.3.620

Editorial

Can we cure limited metastatic breast cancer?

Gabriel N Hortobagyi. J Clin Oncol. 2002.

. 2002 Feb 1;20(3):620-3.

doi: 10.1200/JCO.2002.20.3.620.

Author

Gabriel N Hortobagyi

PMID: 11821439
DOI: 10.1200/JCO.2002.20.3.620

No abstract available

PubMed Disclaimer

Comment on

Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, Barón A, Razook C, Matthes S, Bearman SI. Nieto Y, et al. J Clin Oncol. 2002 Feb 1;20(3):707-18. doi: 10.1200/JCO.2002.20.3.707. J Clin Oncol. 2002. PMID: 11821452

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information